Nov 12, 2013 by Ishtiaq AhmedIs Arena Pharmaceuticals Making Progress?Current price levels make obesity drugmaker Arena Pharmaceuticals an attractive stock to consider.
Nov 4, 2013 by Ishtiaq AhmedQuestcor Is a Solid InvestmentGrowth prospects make Questcor a solid investment.
Oct 25, 2013 by Ishtiaq AhmedIs Alexion Pharmaceuticals a Good Investment?Growth opportunity for orphan drug Soliris makes Alexion Pharmaceuticals an attractive investment.
Oct 21, 2013 by Ishtiaq AhmedIs Isis Pharmaceuticals a Good Investment?Strong pipeline will allow the company to show continued growth
Oct 10, 2013 by Ishtiaq AhmedIs Questcor a Good Investment?There is a lot of room for Questcor to grow its revenues.
Oct 7, 2013 by Ishtiaq AhmedShould You Invest In Orexigen?Obesity drug Contrave will prove to be a game changer for Orexigen.
Oct 3, 2013 by Ishtiaq AhmedIs Alnylam a Good Investment?An Impressive pipeline can be a strong asset for Alnylam Pharmaceuticals.
Aug 22, 2013 by Ishtiaq AhmedWho Will Be the Winner in the Fight Against Obesity?The obesity-drug sector is becoming a battle ground.
Aug 21, 2013 by Ishtiaq AhmedIs Questcor Still Undervalued?Future growth prospects indicate that the biotech stock is still undervalued.
